Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1024

Nonalcoholic fatty liver disease (NAFLD) is a condition in which excessive fatty accumulation in the hepatocytes. There are two types of NAFLD, namely simple fatty liver and non-alcoholic steatohepatitis. In simple fatty liver, the fat in the liver is very less and there is no inflammation or liver cell damage.
In 2018, the global Nonalcoholic Fatty Liver Disease Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Nonalcoholic Fatty Liver Disease Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nonalcoholic Fatty Liver Disease Therapeutics development in United States, Europe and China.

The key players covered in this study
Merck
Pfizer
Novartis
GlaxoSmithKline
Allergan
...

Market segment by Type, the product can be split into
Oral
Parenteral

Market segment by Application, split into
Hospital
Clinic
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Nonalcoholic Fatty Liver Disease Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Nonalcoholic Fatty Liver Disease Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Nonalcoholic Fatty Liver Disease Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Oral
1.4.3 Parenteral
1.5 Market by Application
1.5.1 Global Nonalcoholic Fatty Liver Disease Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Nonalcoholic Fatty Liver Disease Therapeutics Market Size
2.2 Nonalcoholic Fatty Liver Disease Therapeutics Growth Trends by Regions
2.2.1 Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Regions (2014-2025)
2.2.2 Nonalcoholic Fatty Liver Disease Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Manufacturers
3.1.1 Global Nonalcoholic Fatty Liver Disease Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Nonalcoholic Fatty Liver Disease Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Nonalcoholic Fatty Liver Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Nonalcoholic Fatty Liver Disease Therapeutics Key Players Head office and Area Served
3.3 Key Players Nonalcoholic Fatty Liver Disease Therapeutics Product/Solution/Service
3.4 Date of Enter into Nonalcoholic Fatty Liver Disease Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Type (2014-2019)
4.2 Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Nonalcoholic Fatty Liver Disease Therapeutics Market Size (2014-2019)
5.2 Nonalcoholic Fatty Liver Disease Therapeutics Key Players in United States
5.3 United States Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Type
5.4 United States Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Application

6 Europe
6.1 Europe Nonalcoholic Fatty Liver Disease Therapeutics Market Size (2014-2019)
6.2 Nonalcoholic Fatty Liver Disease Therapeutics Key Players in Europe
6.3 Europe Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Type
6.4 Europe Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Application

7 China
7.1 China Nonalcoholic Fatty Liver Disease Therapeutics Market Size (2014-2019)
7.2 Nonalcoholic Fatty Liver Disease Therapeutics Key Players in China
7.3 China Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Type
7.4 China Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Application

8 Japan
8.1 Japan Nonalcoholic Fatty Liver Disease Therapeutics Market Size (2014-2019)
8.2 Nonalcoholic Fatty Liver Disease Therapeutics Key Players in Japan
8.3 Japan Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Type
8.4 Japan Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Nonalcoholic Fatty Liver Disease Therapeutics Market Size (2014-2019)
9.2 Nonalcoholic Fatty Liver Disease Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Type
9.4 Southeast Asia Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Application

10 India
10.1 India Nonalcoholic Fatty Liver Disease Therapeutics Market Size (2014-2019)
10.2 Nonalcoholic Fatty Liver Disease Therapeutics Key Players in India
10.3 India Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Type
10.4 India Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Nonalcoholic Fatty Liver Disease Therapeutics Market Size (2014-2019)
11.2 Nonalcoholic Fatty Liver Disease Therapeutics Key Players in Central & South America
11.3 Central & South America Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Type
11.4 Central & South America Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Application

12 International Players Profiles
12.1 Merck
12.1.1 Merck Company Details
12.1.2 Company Description and Business Overview
12.1.3 Nonalcoholic Fatty Liver Disease Therapeutics Introduction
12.1.4 Merck Revenue in Nonalcoholic Fatty Liver Disease Therapeutics Business (2014-2019)
12.1.5 Merck Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Nonalcoholic Fatty Liver Disease Therapeutics Introduction
12.2.4 Pfizer Revenue in Nonalcoholic Fatty Liver Disease Therapeutics Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Nonalcoholic Fatty Liver Disease Therapeutics Introduction
12.3.4 Novartis Revenue in Nonalcoholic Fatty Liver Disease Therapeutics Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Company Details
12.4.2 Company Description and Business Overview
12.4.3 Nonalcoholic Fatty Liver Disease Therapeutics Introduction
12.4.4 GlaxoSmithKline Revenue in Nonalcoholic Fatty Liver Disease Therapeutics Business (2014-2019)
12.4.5 GlaxoSmithKline Recent Development
12.5 Allergan
12.5.1 Allergan Company Details
12.5.2 Company Description and Business Overview
12.5.3 Nonalcoholic Fatty Liver Disease Therapeutics Introduction
12.5.4 Allergan Revenue in Nonalcoholic Fatty Liver Disease Therapeutics Business (2014-2019)
12.5.5 Allergan Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details